Search
Understanding the complex intersection of environmental regulations intended to combat climate change between now and 2050 while responding to the U.S. tech economy’s exponential growth in energy demand will require collaboration between consumers, industry and government, and reliance upon a...
“PFAS” is an acronym for per- and polyfluoroalkyl substances, a family of thousands of widely used manmade chemicals that resist grease, oil, water and heat. PFAS has been used in firefighting foams, protective coatings and stain-resistant garments and carpets. PFAS are mobile and persistent; they...
PCI, in partnership with Penn Medicine, is pleased to co-host a commercialization speaker series geared toward Penn Medicine faculty, researchers and students. Each session will feature an expert guest speaker as well as time for questions and discussion. The first session will discuss the latest...
The use of artificial intelligence (AI) in health care, and specifically, as the utilization of software in medical devices continues to increase. Machine learning (ML) is a branch of AI in which computer systems automatically adapt, improve, and make predictions by applying algorithms to analyze...
Saul Ewing LLP announced today that it has elected partners Colleen A. Foley and Amy S. Kline to the Firm’s nine-member Executive Committee. Ms. Foley will serve a four-year term, effective immediately. Ms. Kline will serve a five-year term, beginning on January 21, 2023 upon the expiration of...
Kathryn Doyle, a partner at Saul Ewing, will present during the Penn Medicine Commercialization Speaker Series. She will discuss the latest trends in Life Sciences intellectual property on November 17 from 12:00 - 1:00 p.m.
Saul Ewing LLP, a full-service law firm with attorneys in 16 offices, today announced that 59 attorneys from the Firm received the distinguished honor of being recognized for legal excellence and client service by Chambers USA 2022. Several of the Firm’s practice areas also earned high rankings...
Charles M. Lizza and Sarah A. Sullivan of Saul Ewing’s Newark Office secured a precedent-setting victory in a patent infringement case in the Federal District Court for the District of New Jersey involving Janssen Pharmaceuticals, Inc.’s (“J&J”) and Mitsubishi Tanabe Pharma Corp.’s (“MTPC”)...